Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management …
SE Lipshultz, MJ Adams, SD Colan, LS Constine… - Circulation, 2013 - Am Heart Assoc
1928 Circulation October 22, 2013 mental health, functional status, activity limitations,
cancerrelated pain, and cancer-related anxiety) declined moderately to severely in 44%. 5 …
cancerrelated pain, and cancer-related anxiety) declined moderately to severely in 44%. 5 …
ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs–threshold doses for tissue reactions in a …
FA Stewart, AV Akleyev, M Hauer-Jensen, JH Hendry… - Annals of the ICRP, 2012 - Elsevier
This report provides a review of early and late effects of radiation in normal tissues and
organs with respect to radiation protection. It was instigated following a recommendation in …
organs with respect to radiation protection. It was instigated following a recommendation in …
Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline
SH Armenian, C Lacchetti, A Barac, J Carver… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Cardiac dysfunction is a serious adverse effect of certain cancer-directed therapies
that can interfere with the efficacy of treatment, decrease quality of life, or impact the actual …
that can interfere with the efficacy of treatment, decrease quality of life, or impact the actual …
Risk of arterial thromboembolism in patients with cancer
Background: The risk of arterial thromboembolism in patients with cancer is incompletely
understood. Objectives: The authors aimed to better define this epidemiological relationship …
understood. Objectives: The authors aimed to better define this epidemiological relationship …
Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk
FA Van Nimwegen, M Schaapveld… - JAMA internal …, 2015 - jamanetwork.com
Importance Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular
diseases. It is unclear, however, how long the increased risk persists and what the risk …
diseases. It is unclear, however, how long the increased risk persists and what the risk …
Modifiable risk factors and major cardiac events among adult survivors of childhood cancer
GT Armstrong, KC Oeffinger, Y Chen… - Journal of clinical …, 2013 - ascopubs.org
Purpose To evaluate the relative contribution of modifiable cardiovascular risk factors on the
development of major cardiac events in aging adult survivors of childhood cancer. Patients …
development of major cardiac events in aging adult survivors of childhood cancer. Patients …
Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial
L Lowry, P Smith, W Qian, S Falk, K Benstead… - Radiotherapy and …, 2011 - Elsevier
PURPOSE: This multicentre, prospective, randomised-controlled trial compared efficacy and
toxicity of differing radiotherapy doses in non-Hodgkin lymphoma (NHL). PATIENTS AND …
toxicity of differing radiotherapy doses in non-Hodgkin lymphoma (NHL). PATIENTS AND …
Modern radiation therapy for nodal non-Hodgkin lymphoma—target definition and dose guidelines from the International Lymphoma Radiation Oncology Group
Radiation therapy (RT) is the most effective single modality for local control of non-Hodgkin
lymphoma (NHL) and is an important component of therapy for many patients. Many of the …
lymphoma (NHL) and is an important component of therapy for many patients. Many of the …
Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma
DL Hershman, RB McBride, A Eisenberger… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Anthracycline-based chemotherapy, which improves survival for patients with non-
Hodgkin's lymphoma, is often withheld from elderly patients because of its cardiotoxicity. We …
Hodgkin's lymphoma, is often withheld from elderly patients because of its cardiotoxicity. We …
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study
AJ Swerdlow, CD Higgins, P Smith… - Journal of the …, 2007 - academic.oup.com
Background Myocardial infarction is a major cause of excess long-term mortality in survivors
of Hodgkin disease, but limited information exists on the effects of specific chemotherapy …
of Hodgkin disease, but limited information exists on the effects of specific chemotherapy …